Artificial and augmented intelligence are already helping healthcare improve clinically, operationally and financially—and there is extraordinary room for growth. Success starts with leadership, vision and investment and leaders tell us they have all of the above. Read more
Here is an overview of top priorities, barriers to adoption and the mindset of leadership. Healthcare organizations are focused, creating plans and paths to make AI happen. Read more
An increase in the proportion of millennials with chronic health conditions like high blood pressure, high cholesterol and depression could cost the U.S. economy in a big way, the Daily Mail reported Nov. 7.
The CDC has narrowed in on vitamin E acetate as a potential chemical of concern in an epidemic of vaping-related lung illnesses that have injured 2,051 people from nearly all states and have been linked to 39 deaths in 24 states.
Gilead Sciences, a Foster City, California-based biopharmaceutical company, is scheduled to present new AI-powered research related to nonalcoholic steatohepatitis (NASH) at The Liver Meeting 2019 in Boston.
2019 Imaging Innovation Award Winner: Standardization of Clinical Imaging Through Novel Multi-Council Development Within a Large Integrated Healthcare System
